Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1963 Dec;21(3):500–508. doi: 10.1111/j.1476-5381.1963.tb02018.x

A stable substrate for the assay of plasma kinin-forming enzymes

E Amundsen, K Nustad, B Waaler
PMCID: PMC1703873  PMID: 14110750

Abstract

A substrate plasma for estimation of plasma kinin-forming enzyme activity in biological fluids has been prepared from human blood. Fresh citrated plasma was treated by a brief contact with a large amount of silicate powder, followed by heating to 56° C for 1 hr, and finally by lowering its pH to 2 for 10 min. As an alternative to the final treatment with acid, disodium edetate was added to the plasma. The resulting final plasma did not show “spontaneous” plasma kinin activity on contact with glass, contained no kininase activity and did not inhibit plasma kinin enzyme activity of added specimens. The content of plasma kinin precursor in this final plasma was such that it could yield an amount of plasma kinin which corresponded to between 1 and 4 μg of synthetic bradykinin/ml.

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMSTRONG D., JEPSON J. B., KEELE C. A., STEWART J. W. Activation by glass of pharmacologically active agents in blood of various species. J Physiol. 1955 Sep 28;129(3):80–1P. doi: 10.1113/jphysiol.1955.sp005387. [DOI] [PubMed] [Google Scholar]
  2. ARMSTRONG D., JEPSON J. B., KEELE C. A., STEWART J. W. Pain-producing substance in human inflammatory exudates and plasma. J Physiol. 1957 Feb 15;135(2):350–370. doi: 10.1113/jphysiol.1957.sp005715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. ARMSTRONG D., KEELE C. A., JEPSON J. B., STEWART J. W. Development of pain-producing substance in human plasma. Nature. 1954 Oct 23;174(4434):791–792. doi: 10.1038/174791a0. [DOI] [PubMed] [Google Scholar]
  4. DINIZ C. R., CARVALHO I. F., RYAN J., ROCHA E SILVA M. A micromethod for the determination of bradykininogen in blood plasma. Nature. 1961 Dec 23;192:1194–1195. doi: 10.1038/1921194a0. [DOI] [PubMed] [Google Scholar]
  5. ERDOS E. G., SLOANE E. M. An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem Pharmacol. 1962 Jul;11:585–592. doi: 10.1016/0006-2952(62)90119-3. [DOI] [PubMed] [Google Scholar]
  6. HORTON E. W. The estimation of urinary kallkrein. J Physiol. 1959 Oct;148:267–282. doi: 10.1113/jphysiol.1959.sp006287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. LEWIS G. P. Active polypeptides derived from plasma proteins. Physiol Rev. 1960 Oct;40:647–676. doi: 10.1152/physrev.1960.40.4.647. [DOI] [PubMed] [Google Scholar]
  8. MARGOLIS J. Hageman factor in plasma foreign surface reactions. Nature. 1958 Oct 18;182(4642):1102–1103. doi: 10.1038/1821102a0. [DOI] [PubMed] [Google Scholar]
  9. MARGOLIS J. The interrelationship of coagulation of plasma and release of peptides. Ann N Y Acad Sci. 1963 Feb 4;104:133–145. doi: 10.1111/j.1749-6632.1963.tb17659.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES